Ontology highlight
ABSTRACT:
SUBMITTER: Bellet M
PROVIDER: S-EPMC6535716 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Bellet Meritxell M Ahmad Faten F Villanueva Rafael R Valdivia Carolina C Palomino-Doza Julián J Ruiz Ada A Gonzàlez Xavier X Adrover Encarna E Azaro Analía A Valls-Margarit Maria M Parra Josep Lluís JL Aguilar Juan J Vidal Maria M Martín Anastasi A Gavilá Joaquín J Escrivá-de-Romaní Santiago S Perelló Antonia A Hernando Cristina C Lahuerta Ainhara A Zamora Pilar P Reyes Victoria V Alcalde María M Masanas Helena H Céliz Pamela P Ruíz Isabel I Gil Miguel M Seguí Miguel Àngel MÀ de la Peña Lorena L
Therapeutic advances in medical oncology 20190510
Drug-drug interactions are of significant concern in clinical practice in oncology, particularly in patients receiving Cyclin-dependent kinase (CDK) 4/6 inhibitors, which are typically exposed to long-term regimens. This article presents the highlights from the 'First Workshop on Pharmacology and Management of CDK4/6 Inhibitors: Consensus about Concomitant Medications'. The article is structured into two modules. The educational module includes background information regarding drug metabolism, c ...[more]